| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | arylsulfatase activity | 1.47e-04 | 14 | 26 | 2 | GO:0004065 | |
| GeneOntologyMolecularFunction | sulfuric ester hydrolase activity | 2.19e-04 | 17 | 26 | 2 | GO:0008484 | |
| GeneOntologyMolecularFunction | RNA exonuclease activity | 1.56e-03 | 45 | 26 | 2 | GO:0004532 | |
| GeneOntologyCellularComponent | lysosomal lumen | 2.13e-04 | 98 | 25 | 3 | GO:0043202 | |
| HumanPheno | Abnormal glycosphingolipid metabolism | 1.51e-04 | 11 | 9 | 2 | HP:0004343 | |
| HumanPheno | Left-to-right shunt | 1.51e-04 | 11 | 9 | 2 | HP:0012382 | |
| HumanPheno | Systolic heart murmur | 2.14e-04 | 13 | 9 | 2 | HP:0031664 | |
| HumanPheno | ST segment depression | 2.14e-04 | 13 | 9 | 2 | HP:0012250 | |
| HumanPheno | Increased pulmonary vascular resistance | 2.14e-04 | 13 | 9 | 2 | HP:0005317 | |
| HumanPheno | Progressive psychomotor deterioration | 2.14e-04 | 13 | 9 | 2 | HP:0007272 | |
| HumanPheno | Cardiac shunt | 2.88e-04 | 15 | 9 | 2 | HP:0001693 | |
| HumanPheno | Abnormality of glycolipid metabolism | 3.29e-04 | 16 | 9 | 2 | HP:0010969 | |
| HumanPheno | Abnormality of liposaccharide metabolism | 3.29e-04 | 16 | 9 | 2 | HP:0010968 | |
| HumanPheno | Right ventricular dilatation | 3.72e-04 | 17 | 9 | 2 | HP:0005133 | |
| HumanPheno | Right ventricular failure | 4.18e-04 | 18 | 9 | 2 | HP:0001708 | |
| HumanPheno | Abnormal right ventricular function | 5.73e-04 | 21 | 9 | 2 | HP:0033118 | |
| HumanPheno | Atrial flutter | 5.73e-04 | 21 | 9 | 2 | HP:0004749 | |
| Domain | Sulfatase_CS | 2.21e-04 | 16 | 26 | 2 | IPR024607 | |
| Domain | SULFATASE_1 | 2.50e-04 | 17 | 26 | 2 | PS00523 | |
| Domain | SULFATASE_2 | 2.50e-04 | 17 | 26 | 2 | PS00149 | |
| Domain | Sulfatase | 2.81e-04 | 18 | 26 | 2 | PF00884 | |
| Domain | Sulfatase_N | 2.81e-04 | 18 | 26 | 2 | IPR000917 | |
| Domain | Alkaline_phosphatase_core | 8.45e-04 | 31 | 26 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 8.45e-04 | 31 | 26 | 2 | IPR017849 | |
| Domain | - | 8.45e-04 | 31 | 26 | 2 | 3.40.720.10 | |
| Domain | Homeobox | 4.08e-03 | 234 | 26 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 4.18e-03 | 236 | 26 | 3 | PS00027 | |
| Domain | HOX | 4.23e-03 | 237 | 26 | 3 | SM00389 | |
| Domain | Homeobox_dom | 4.33e-03 | 239 | 26 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 4.33e-03 | 239 | 26 | 3 | PS50071 | |
| Domain | - | 6.92e-03 | 283 | 26 | 3 | 1.10.10.60 | |
| Domain | Homeodomain-like | 1.07e-02 | 332 | 26 | 3 | IPR009057 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 1.16e-07 | 39 | 17 | 4 | M48042 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 1.32e-07 | 107 | 17 | 5 | M14857 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 5.90e-07 | 58 | 17 | 4 | M576 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 3.79e-06 | 92 | 17 | 4 | MM15086 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_CATABOLISM | 8.52e-06 | 34 | 17 | 3 | MM17076 | |
| Pathway | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | 3.29e-05 | 53 | 17 | 3 | MM14647 | |
| Pathway | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | 1.06e-04 | 13 | 17 | 2 | M663 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 1.75e-04 | 757 | 17 | 6 | M27451 | |
| Pathway | WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES | 1.84e-04 | 17 | 17 | 2 | M39638 | |
| Pathway | KEGG_SPHINGOLIPID_METABOLISM | 9.88e-04 | 39 | 17 | 2 | M15955 | |
| Pathway | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | 2.03e-03 | 56 | 17 | 2 | M839 | |
| Pathway | KEGG_RNA_DEGRADATION | 2.25e-03 | 59 | 17 | 2 | M963 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION | 2.40e-03 | 61 | 17 | 2 | M26993 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 7579515 | ||
| Pubmed | Analysis of the HEXA, HEXB, ARSA, and SMPD1 Genes in 68 Iranian Patients. | 3.22e-06 | 4 | 26 | 2 | 34554397 | |
| Pubmed | TBX20 inhibits colorectal cancer tumorigenesis by impairing NHEJ-mediated DNA repair. | 3.22e-06 | 4 | 26 | 2 | 35348274 | |
| Pubmed | Development and maturation of invariant NKT cells in the presence of lysosomal engulfment. | 5.37e-06 | 5 | 26 | 2 | 19637231 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 11919180 | ||
| Pubmed | A role for HOX13 proteins in the regulatory switch between TADs at the HoxD locus. | 1.50e-05 | 8 | 26 | 2 | 27198226 | |
| Pubmed | Functional analysis of CTCF during mammalian limb development. | 3.53e-05 | 12 | 26 | 2 | 21145498 | |
| Pubmed | Distal Limb Patterning Requires Modulation of cis-Regulatory Activities by HOX13. | 6.41e-05 | 16 | 26 | 2 | 27974206 | |
| Pubmed | Multiple enhancers regulate Hoxd genes and the Hotdog LncRNA during cecum budding. | 7.26e-05 | 17 | 26 | 2 | 24075990 | |
| Pubmed | 8.16e-05 | 18 | 26 | 2 | 25220460 | ||
| Pubmed | 1.47e-04 | 24 | 26 | 2 | 33722704 | ||
| Pubmed | 1.86e-04 | 27 | 26 | 2 | 23096701 | ||
| Pubmed | 2.38e-04 | 772 | 26 | 5 | 16341674 | ||
| Pubmed | Genome-wide association study of periodontal pathogen colonization. | 2.47e-04 | 31 | 26 | 2 | 22699663 | |
| Pubmed | Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. | 2.63e-04 | 32 | 26 | 2 | 17883393 | |
| Pubmed | 2.80e-04 | 33 | 26 | 2 | 24705356 | ||
| Pubmed | 2.93e-04 | 808 | 26 | 5 | 20412781 | ||
| Pubmed | 3.15e-04 | 35 | 26 | 2 | 15188402 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.50e-04 | 457 | 26 | 4 | 32344865 | |
| Pubmed | 4.16e-04 | 196 | 26 | 3 | 21862448 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.83e-04 | 220 | 26 | 3 | 35785414 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 6.73e-04 | 544 | 26 | 4 | 28473536 | |
| GeneFamily | Sulfatases | 8.46e-05 | 18 | 14 | 2 | 410 | |
| GeneFamily | HOXL subclass homeoboxes | 7.22e-04 | 52 | 14 | 2 | 518 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN | 3.60e-05 | 191 | 26 | 4 | M9973 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN | 4.23e-05 | 199 | 26 | 4 | M4457 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 6.21e-05 | 12 | 26 | 2 | M34000 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.94e-06 | 186 | 26 | 4 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.28e-06 | 190 | 26 | 4 | ce70336679a2b713836e7497e6dc48aac612b018 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.14e-04 | 163 | 26 | 3 | 0e8d3c98209fc98b86b841d69051cee9e276d837 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 166 | 26 | 3 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 166 | 26 | 3 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 167 | 26 | 3 | 881f64db8dea3faa7588bf04d87c20924a4e5952 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 178 | 26 | 3 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 1.51e-04 | 179 | 26 | 3 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 189 | 26 | 3 | f2daf4889ef98bbefe3e44832618ac102a75b4d9 | |
| ToppCell | COVID-19_Mild-Lymphoid_P|COVID-19_Mild / Disease group, lineage and cell class | 1.77e-04 | 189 | 26 | 3 | 0b3d3bd697e79decae7e21c513fab9da3b2a47c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-04 | 189 | 26 | 3 | c296660061b46e3abae1e7cf29df20274e5a8add | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 189 | 26 | 3 | 73ee4cfb1057832f700be59b6917dedde3e89880 | |
| ToppCell | COVID-19_Mild-Lymphoid_P-Plasmablast|COVID-19_Mild / Disease group, lineage and cell class | 1.77e-04 | 189 | 26 | 3 | 254f058850b41a5974a380f3710db7c01a51fb6b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-04 | 189 | 26 | 3 | 9de17ade3cc3e9cd1394338bd048fb1ce64ac50f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-04 | 189 | 26 | 3 | 31594cc59eb1c5b01407dfd72b1487ecca8bf5ec | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.79e-04 | 190 | 26 | 3 | 1f907016980ccfbf089e354d91d931771e8a83e0 | |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | 1.82e-04 | 191 | 26 | 3 | bb28703020c5296b65527094d2e5924348275e58 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 1.85e-04 | 192 | 26 | 3 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 1.85e-04 | 192 | 26 | 3 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 1.85e-04 | 192 | 26 | 3 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | B_cell_maturation-plasma|B_cell_maturation / Lineage and Cell class | 1.88e-04 | 193 | 26 | 3 | 5415f7e54bc40aec3dbe27fd97f6e9be6db08a48 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-04 | 193 | 26 | 3 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.88e-04 | 193 | 26 | 3 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-04 | 193 | 26 | 3 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.88e-04 | 193 | 26 | 3 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 193 | 26 | 3 | b9c00df1b216eaa4283315713f1c9ef552d3d435 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-04 | 193 | 26 | 3 | 1f50823bd7ef00500d9d81f0f5c2f6c940c4b1a6 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 1.88e-04 | 193 | 26 | 3 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.88e-04 | 193 | 26 | 3 | d05535eaabb6b4069b72b23d852888d4191407fd | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.88e-04 | 193 | 26 | 3 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.91e-04 | 194 | 26 | 3 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.91e-04 | 194 | 26 | 3 | 1ca034f25a8fce503fb67654d7fa2a8ec71976be | |
| ToppCell | MS-plasma|MS / Condition, Cell_class and T cell subcluster | 1.94e-04 | 195 | 26 | 3 | de866c0eaec36d94a3101eb9f949ca9544207f33 | |
| ToppCell | MS-plasma-|MS / Condition, Cell_class and T cell subcluster | 1.94e-04 | 195 | 26 | 3 | b0a51dea06899e6a4477c3436c85e114cd8f6214 | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.94e-04 | 195 | 26 | 3 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.97e-04 | 196 | 26 | 3 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.97e-04 | 196 | 26 | 3 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.97e-04 | 196 | 26 | 3 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.00e-04 | 197 | 26 | 3 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | mLN-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 2.00e-04 | 197 | 26 | 3 | 2071526fe46de8359ea118ff78581eb4454aa55a | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 197 | 26 | 3 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.00e-04 | 197 | 26 | 3 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | (08)_Brush+PNEC|World / shred by cell type by condition | 2.06e-04 | 199 | 26 | 3 | f2e33cb569c25fc2732722cac295647e9bd8738f | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 2.06e-04 | 199 | 26 | 3 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-04 | 199 | 26 | 3 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class | 2.06e-04 | 199 | 26 | 3 | 46f31aef26c3da7608082f750d743ad54adbc51a | |
| ToppCell | (2)_B_cell-(21)_B_cell_IgG_Plasma|(2)_B_cell / shred on Cell_type and subtype | 2.09e-04 | 200 | 26 | 3 | 2831060d52b210f8927527810611735a99b61999 | |
| Computational | Genes in the cancer module 346. | 3.55e-04 | 17 | 18 | 2 | MODULE_346 | |
| Computational | Genes in the cancer module 408. | 3.99e-04 | 18 | 18 | 2 | MODULE_408 | |
| Disease | Ostium secundum atrial septal defect | 2.27e-05 | 9 | 24 | 2 | C0344724 | |
| Disease | ventricular septal defect (is_implicated_in) | 5.74e-05 | 14 | 24 | 2 | DOID:1657 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 2.31e-03 | 702 | 24 | 4 | C0009402 | |
| Disease | diffuse plaque measurement | 3.05e-03 | 758 | 24 | 4 | EFO_0010699 | |
| Disease | total blood protein measurement | 5.59e-03 | 449 | 24 | 3 | EFO_0004536 | |
| Disease | stomach cancer (is_marker_for) | 5.92e-03 | 142 | 24 | 2 | DOID:10534 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HPLNHGFHYFYGVPF | 131 | Q5FYA8 | |
| PLSIHHYFHGYLAGF | 516 | Q9BQT9 | |
| YDYLSLYDGHPHPTN | 116 | Q7Z407 | |
| YPFHSHVPLHYYPHV | 276 | Q03828 | |
| AAAYYHPSYLAPHPF | 246 | Q14687 | |
| YLHYLPSYYHLHVHF | 266 | Q96C86 | |
| HNYPFQPLSSGLYHY | 176 | Q8N5B7 | |
| YLIHHYHPCYVPFDA | 1146 | Q8IZT6 | |
| GSAYLPSYHHSPYKH | 856 | Q9UPQ7 | |
| LYYASHHTHYPQFSG | 221 | P15289 | |
| HIYTLNGYPYMIHHG | 96 | O60906 | |
| PCGLYHQYHLAGHYA | 166 | Q1HG44 | |
| HYYDPLQFQGPIYTH | 546 | O15234 | |
| GHEYYYISTPTHNLH | 141 | P52797 | |
| NIIHPYYHPYSGSQE | 371 | Q3MJ40 | |
| NIIHPYYHPYSGSQE | 371 | A2RUR9 | |
| YHGYIFGFYKWHHEP | 101 | P07686 | |
| PHYQYIPHLFSYSGH | 221 | Q15406 | |
| GSVYYYPSYHHQHNP | 711 | O95486 | |
| YSLPFSYHYGHFPLD | 436 | Q14190 | |
| TQSEYKPPIYHFYSH | 86 | Q96PL2 | |
| YHQGYAAGPYHHHQP | 231 | P31271 | |
| HKGHPHTSYYQYGLG | 146 | P20062 | |
| NQYFNHHPYPHNHYM | 121 | Q99967 | |
| PPYGYSDQSYHTHLL | 981 | O15014 | |
| YPYHYAPFLSDIHNI | 481 | Q8IZH2 | |
| PTFPSFHMPRYHHYF | 411 | Q9UMR3 | |
| FHMPRYHHYFQQGPY | 416 | Q9UMR3 |